Mild asthma.

被引：7

作者：

Naureckas, ET ^{[1
]}

Solway, J ^{[1
]}

机构：

[1] Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2001年 / 345卷 / 17期

关键词：

D O I：

10.1056/NEJMcp010434

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1257 / 1262

页数：6

共 30 条

[1] Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma [J].

Bleecker, ER ;

Welch, MJ ;

Weinstein, SF ;

Kalberg, C ;

Johnson, M ;

Edwards, L ;

Rickard, KA .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (06) :1123-1129

[2] Airways remodeling is a distinctive feature of asthma and is related to severity of disease [J].

Chetta, A ;

Foresi, A ;

DelDonno, M ;

Bertorelli, G ;

Pesci, A ;

Olivieri, D .

CHEST, 1997, 111 (04) :852-857

[3]

*CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343

[4] Categorizing asthma severity [J].

Colice, GL ;

Vanden Burgt, J ;

Song, J ;

Stampone, P ;

Thompson, PJ .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (06) :1962-1967

[5]

Coreno A, 2000, J ALLERGY CLIN IMMUN, V106, P500

[6] Comparison of regularly scheduled with as-needed use of albuterol in mild asthma [J].

Drazen, JM ;

Israel, E ;

Boushey, HA ;

Chinchilli, VM ;

Fahy, JV ;

Fish, JE ;

Lazarus, SC ;

Lemanske, RF ;

Martin, RJ ;

Peters, SP ;

Sorkness, C ;

Szefler, SJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12) :841-847

[7]

Drazen JM, 1999, NEW ENGL J MED, V340, P663

[8] Treatment of asthma with drugs modifying the leukotriene pathway [J].

Drazen, JM ;

Israel, E ;

O'Byrne, PM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (03) :197-206

[9] EFFECTS OF REDUCING OR DISCONTINUING INHALED BUDESONIDE IN PATIENTS WITH MILD ASTHMA [J].

HAAHTELA, T ;

JARVINEN, M ;

KAVA, T ;

KIVIRANTA, K ;

KOSKINEN, S ;

LEHTONEN, K ;

NIKANDER, K ;

PERSSON, T ;

SELROOS, O ;

SOVIJARVI, A ;

STENIUSAARNIALA, B ;

SVAHN, T ;

TAMMIVAARA, R ;

LAITINEN, LA .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (11) :700-705

[10] COMPARISON OF A BETA-2-AGONIST, TERBUTALINE, WITH AN INHALED CORTICOSTEROID, BUDESONIDE, IN NEWLY DETECTED ASTHMA [J].